Improving survival after endometrial cancer: the big picture - Wikidata - awgldk - TriplyDB

Improving survival after endometrial cancer: the big picture

Improving survival after endometrial cancer: the big picture

http://www.wikidata.org/entity/Q26801354

about

MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer.

P2860

Q36879574-57A25B86-ACBF-4B82-A805-1CB18BC3DA24 Q38751082-151FA453-0292-4AC1-80D8-430ED3D2740D Q53449580-EBF54C47-BF3B-4D9A-B54F-4CA07284F76E

P2860

Improving survival after endometrial cancer: the big picture

http://www.wikidata.org/entity/Q26801354

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Improving survival after endometrial cancer: the big picture

@ast

Improving survival after endometrial cancer: the big picture

@en

Improving survival after endometrial cancer: the big picture

@nl

type

label

Improving survival after endometrial cancer: the big picture

@ast

Improving survival after endometrial cancer: the big picture

@en

Improving survival after endometrial cancer: the big picture

@nl

prefLabel

Improving survival after endometrial cancer: the big picture

@ast

Improving survival after endometrial cancer: the big picture

@en

Improving survival after endometrial cancer: the big picture

@nl

P1433

Q26801354-14E5BBA4-E965-4BB4-B19B-249A8E6BEAE9

P1476

Q26801354-D2DA7C08-015C-4C4F-8B6E-39D4FC034AC3

P2093

Q26801354-21AD0675-4FF5-4B75-B102-74E070781F73

P275

Q26801354-F8349FE0-B576-4369-816F-D80C8CC7FEC3

P2860

Q26801354-1AF2A136-42BC-433D-9B76-8E65D7AE6215

Q26801354-2E858A5E-E60E-4CF6-B242-AEDC445C4250

Q26801354-3195EDE7-BC89-4A0A-801B-0EE8E3E91A92

Q26801354-340EC0E8-2F45-450E-84C1-D9704444B24B

Q26801354-3BAF427E-4D5B-4220-B600-5042A939275D

Q26801354-42CAB932-4E6B-40F5-938D-0857F034E98A

Q26801354-4870548A-3299-48FC-ABA4-4BE24E364994

Q26801354-49E648EF-F1B2-42B1-9B49-E20ADECC17AE

Q26801354-65A3DB7A-7112-4639-B814-30DC39FCD9A1

Q26801354-7F1522FE-28D3-4297-986C-8A1AF16506CA

P304

Q26801354-A9EED58D-7EA1-4613-AE92-34C08822EE31

P31

Q26801354-3AECD4C6-3B68-432C-AFA4-EF82738250EB

Q26801354-B23BD065-71D7-4A75-BED2-8F0849B63376

P356

Q26801354-BA79FC1C-AC07-45EB-8F9D-D6F6F5185F96

P407

Q26801354-A60572A0-59D1-4FDA-9DCA-35ED6134911F

P433

Q26801354-BA2F3F7F-FF52-43C3-945A-F424E7742E63

P478

Q26801354-F5CF5CD8-175C-49D9-BB92-F88DF13B32FB

P5008

Q26801354-34CF2E59-245F-4A93-B535-AC2E5EFCFDC5

P577

Q26801354-54268DF1-D122-48C6-A6EE-705DA5ABC432

Q26801354-B40AD7BB-3AC5-46ED-9B61-6A5E811AF83A

P5875

Q26801354-E12F9D53-B03D-450E-AAFB-2A5B3975174F

P698

Q26801354-C2643419-16C6-4438-88C0-6741CE1E4A01

P921

Q26801354-0C70D95B-C40B-42E0-A950-E131635347F3

Q26801354-2004C9AB-D5D8-47D9-95F3-E45F87A099C8

Q26801354-7F91A029-FAE6-4497-BF6D-7E5AB208E636

Q26801354-FF809060-4EDC-4167-ABC0-5FF734BE5028

P932

Q26801354-5D192437-7B25-4EC7-9956-77BD4EF729BD

P356

JGO.2015.26.3.227

P1433

Journal of gynecologic oncology

P1476

Improving survival after endometrial cancer: the big picture

@en

P2093

Janice S Kwon

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer.

Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Gynecologic Cancers in Lynch Syndrome/HNPCC.

P304

227-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2015.26.3.227

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280388871

http://www.w3.org/2001/XMLSchema#string

P698

26197859

http://www.w3.org/2001/XMLSchema#string

P921

endometrial carcinoma

endometrial neoplasm

obstetrics and gynaecology

endometrial cancer

P932

4510340

http://www.w3.org/2001/XMLSchema#string